You just read:

EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture

News provided by

Amgen

Oct 18, 2019, 01:00 ET